DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Aldactone (Spironolactone) - Adverse Event Reports - Death - Hyperkalaemia

 



Index of reports > Cases resulting in death (25) > Cases with Hyperkalaemia (5)

Below is the selection of adverse event reports related to Aldactone (Spironolactone) that includes cases resulting in death where reactions include hyperkalaemia.

Adverse event in 95 year old female receiving Aldactone (Spironolactone)

Reported by a consumer/non-health professional from France on 2007-04-16

Patient: 95 year old female

Adverse reactions / side effects: OFF Label USE, Acute Pulmonary Oedema, Right Ventricular Failure, Cardiac Failure, Hyperkalaemia, Oedema Peripheral, Acidosis, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Suspect drug(s):
Allopurinol
    Administration route: Oral

Avandia
    Administration route: Oral

Aldactone
    Administration route: Oral

Colchimax
    Administration route: Oral

Lasix
    Administration route: Oral

Fozitec
    Administration route: Oral

Other drugs received by patient: Adancor; Kardegic; Cardensiel; Pariet; Stablon; Alprazolam; Zolpidem; Aluminum Hydroxide and Magnesium Trisilicate; Arestal



Adverse event in 86 year old female receiving Aldactone (Spironolactone)

Reported by a physician from Japan on 2007-03-16

Patient: 86 year old female

Adverse reactions / side effects: Hyperkalaemia

Adverse event resulted in: death, life threatening event

Suspect drug(s):
Cozaar
    Administration route: Oral
    Indication: Hypertension
    Start date: 2006-08-03
    End date: 2007-02-07

Aldactone
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2004-04-07
    End date: 2007-02-07

Other drugs received by patient: Lasix; Takepron; Lendormin; Zolpidem Tartrate; Pursennid; Argamate Jelly



Adverse event in 86 year old female receiving Aldactone (Spironolactone)

Reported by a physician from Japan on 2007-03-09

Patient: 86 year old female

Adverse reactions / side effects: Hyperkalaemia

Adverse event resulted in: death, life threatening event

Suspect drug(s):
Cozaar
    Administration route: Oral
    Indication: Hypertension
    Start date: 2006-08-03
    End date: 2007-02-07

Aldactone
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2004-04-07
    End date: 2007-02-07

Other drugs received by patient: Pursennid; Argamate Jelly; Lasix; Takepron; Lendormin; Zolpidem Tartrate



Adverse event in 86 year old female receiving Aldactone (Spironolactone)

Reported by a physician from Japan on 2007-02-22

Patient: 86 year old female

Adverse reactions / side effects: Renal Failure, Hyperkalaemia

Adverse event resulted in: death

Suspect drug(s):
Cozaar
    Administration route: Oral

Aldactone
    Administration route: Oral



Adverse event in receiving Aldactone (Spironolactone)

Reported by a physician from Japan on 2007-02-20

Patient:

Adverse reactions / side effects: Hyperkalaemia

Adverse event resulted in: death

Suspect drug(s):
Cozaar
    Administration route: Oral

Aldactone
    Administration route: Oral

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009